An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02429947

Enrollment

411

Registered

2015-04-29

Start date

2012-07-31

Completion date

2013-06-30

Last updated

2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Charcot Marie Tooth Disease (CMT), Congenital Abnormalities, Genetic Diseases, Inborn, Hereditary Sensory and Motor Neuropathy, Heredodegenerative Disorders, Nervous System, Nerve Compression Syndromes, Tooth Diseases

Keywords

Charcot Marie Tooth disease, CMT, HMSN, HMN, HSN

Brief summary

The purpose of this study is to identify the issues that have greatest impact on QOL for patients with Charcot Marie Tooth (CMT) Disease. Patients who have -registered in the Inherited Neuropathies Consortium Contact Registry will be invited to participate.

Detailed description

The protocol consists of two anonymous surveys. The first large scale survey is designed to identify items that best reflect the issues and symptoms with high impact upon QOL in CMT. A second brief survey focuses on the frequency and impact of muscle cramps on QOL in adult CMT. The surveys will be distributed via an online link to all adult CMT patients self-registered with the RDCRN contact registry. Those who complete the first two surveys will be requested to complete only the second brief survey on muscle cramps again 3 weeks after completing it the first time. Those who complete the brief muscle cramps survey a second time will be requested to complete it again 5 weeks later to assess variability in occurrence of muscle cramps. The first large scale survey to identify items that best reflect the issues and symptoms with high impact upon QOL in CMT will be sent out in a second wave. This second wave will only contain the QOL survey and not the muscle cramp survey. The QOL survey will be distributed via an online link to three populations: adult CMT patients self-registered with the INC (RDCRN) Contact Registry who had not been registered at the time of the first enrollment period, adult patients who had been registered at the time of the first enrollment period and had received the survey, but had not returned it, and patients who were registered, but were under age 18 at the time of the first enrollment period and have turned 18 by the time of the second enrollment period.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with CMT that are 18 years or older and have joined the INC RDCRN Contact Registry.

Exclusion criteria

* Does not have CMT. * Does not read or speak English.

Design outcomes

Primary

Measure	Time frame	Description
Percentage of participants affected by specific symptoms of CMT.	1 year	The percentage of subjects within the sample who have reported experience with the symptom will be calculated.

Secondary

Measure	Time frame	Description
Severity of impact of each identified symptom of CMT	1 year	The symptoms will be rank ordered with symptoms that affect life severely receiving the highest rank.

Countries

United States

Outcome results